BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32707135)

  • 21. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
    Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
    Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
    Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
    Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.
    Ma L; Tian X; Wang F; Zhang Z; Du C; Xie X; Kornmann M; Yang Y
    Cancer Biol Ther; 2016 Oct; 17(10):1051-1061. PubMed ID: 27573434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation.
    Li Z; Ge Y; Dong J; Wang H; Zhao T; Wang X; Liu J; Gao S; Shi L; Yang S; Huang C; Hao J
    Gastroenterology; 2022 Apr; 162(4):1256-1271.e14. PubMed ID: 34951995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.
    Gao CC; Xu QQ; Xiao FJ; Wang H; Wu CT; Wang LS
    Biochem Biophys Res Commun; 2020 May; 526(2):431-438. PubMed ID: 32228887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.
    Shi HH; Liu HE; Luo XJ
    BMB Rep; 2020 Dec; 53(12):658-663. PubMed ID: 33298240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y; Pan C; Hu X; Ma Y
    Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
    Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
    Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
    Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma.
    Bai Z; Du Y; Cong L; Cheng Y
    Gene; 2020 Oct; 758():144960. PubMed ID: 32687947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity for Kras
    Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
    Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.
    Li S; Hong H; Lv H; Wu G; Wang Z
    Med Sci Monit; 2016 May; 22():1593-600. PubMed ID: 27170223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
    Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
    J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
    Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
    Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.